A carefully engineered gold catalyst has just pushed green chemistry into new territory, setting a performance benchmark that ...

This study presents a highly efficient approach to solar hydrogen production by pairing water electrolysis with the selective oxidation of biomass-derived glucose. Central to this advance is a ...

Catalyst is offering patients and their caregivers a personalized program called Catalyst Pathways to provide guidance and financial support. Agamree ® (vamorolone) oral suspension has been made ...

A new cobalt catalyst designed by Paul Chirik and coworkers at Princeton University gives chemists two mechanisms for the price of one. The team’s alkene hydrogenation reaction runs differently ...

"Throughout 2025, we have continued to execute on our commercial growth initiatives to drive adoption of FIRDAPSE® and AGAMREE®, resulting in another quarter of strong financial performance," stated ...

This archived news story is available only for your personal, non-commercial use. Information in the story may be outdated or superseded by additional information. Reading or replaying the story in ...

CORAL GABLES, Fla., Sept. 30, 2021 (GLOBE NEWSWIRE) -- Catalyst Pharmaceuticals, Inc. (Catalyst) (Nasdaq: CPRX), a commercial-stage, patient-centric biopharmaceutical company focused on in-licensing, ...

Like many biotech stocks, Catalyst Pharmaceuticals (CPRX 2.53%) has quickly rebounded from the low point it reached during the first quarter's pandemic-driven market plunge. The stock is up about 31% ...

Conte signaled ongoing milestones, stating the company expects “proof-of-concept results from these investigator-initiated trials throughout 2025 and potentially even into 2026,” while Phase 2 trials ...

CORAL GABLES, Fla., Nov. 05, 2025 (GLOBE NEWSWIRE) -- Catalyst Pharmaceuticals (CPRX), Inc. today reported financial results for the third quarter of 2025 and provided a business update. “Throughout ...